A Mismatch Repair-Deficient Hepatoid Adenocarcinoma of the Lung Responding to Anti-PD-L1 Durvalumab Therapy Despite no PD-L1 Expression.

Saved in:
Bibliographic Details
Title: A Mismatch Repair-Deficient Hepatoid Adenocarcinoma of the Lung Responding to Anti-PD-L1 Durvalumab Therapy Despite no PD-L1 Expression.
Authors: Basse V; Department of Oncology, CHRU Brest, Brest, France., Schick U; Department of Radiotherapy, CHRU Brest, Brest, France., Guéguen P; Department of Moleculra Genetics, CHRU Brest, Brest, France., Le Maréchal C; Department of Moleculra Genetics, CHRU Brest, Brest, France., Quintin-Roué I; Department of Pathology, CHRU Brest, Brest, France., Descourt R; Department of Oncology, CHRU Brest, Brest, France., Simon H; Department of Oncology, CHRU Brest, Brest, France., Uguen A; Department of Pathology, CHRU Brest, Brest, France. Electronic address: arnaud.uguen@chu-brest.fr., Quéré G; Department of Oncology, CHRU Brest, Brest, France.
Source: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2018 Jul; Vol. 13 (7), pp. e120-e122.
Publication Type: Case Reports; Letter
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1556-1380
DOI:10.1016/j.jtho.2018.03.004